Editorial: New drugs in lipid lowering therapy

• by Ibadete Bytyçi, Maciej Banach, Ivan Pećin

• May 28, 2026

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• May 29, 2026

• 3 min

Active endothelial and neural regulation of valve biology, health, and disease

• by G. Janani, Kenny L. Nguyen, Jonathan T. Butcher

• May 29, 2026

Patients with type 1 diabetes mellitus and recommended low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B targets – a SwissDiab study

• by Christina Liu, Frida Renström, Giacomo Gastaldi, Michael Brändle, Stefan Bilz

• May 29, 2026